Unresectable giant pancreatic neuroendocrine tumor effectively treated by high-intensity focused ultrasound: A case report and review of the literature

This publication has 14 references indexed in Scilit:

• Phase 2 study of everolimus monotherapy in patients with nonfunctioning neuroendocrine tumors or pheochromocytomas/paragangliomas
  Cancer, 2012
• Analgesic effect of high intensity focused ultrasound therapy for unresectable pancreatic cancer
  International Journal of Hyperthermia, 2011
• Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
  New England Journal of Medicine, 2011
• Current and Future Clinical Applications of High-Intensity Focused Ultrasound (HIFU) for Pancreatic Cancer
  Gut and Liver, 2010
• Dendritic Cells Loaded with Ultrasound-Ablated Tumour Induce in vivo Specific Antitumour Immune Responses
  Ultrasound in Medicine & Biology, 2010
• Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
  Journal of Clinical Oncology, 2009
• Medical Management of Pancreatic Neuroendocrine Tumors
  American Journal of Gastroenterology, 2008
• Host antitumour immune responses to HIFU ablation
  International Journal of Hyperthermia, 2007
• Surgical Strategy for Large or Malignant Endocrine Pancreatic Tumors
  World Journal of Surgery, 2000
• Streptozocin–Doxorubicin, Streptozocin–Fluorouracil, or Chlorozotocin in the Treatment of Advanced Islet-Cell Carcinoma
  New England Journal of Medicine, 1992